GHETTI, Gianni; PORTA, Camilla; POVERO, Massimiliano. Retifanlimab Vs Avelumab in Patients with Metastatic Merkel Cell Carcinoma: A Cost Utility Analysis in Italy. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 26, n. 1, 2025. DOI: 10.7175/fe.v26i1.1574. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/1574. Acesso em: 22 jul. 2025.